These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 20691267

  • 21. Characterization of the human immune response to the UK anthrax vaccine.
    Baillie L, Townend T, Walker N, Eriksson U, Williamson D.
    FEMS Immunol Med Microbiol; 2004 Oct 01; 42(2):267-70. PubMed ID: 15364114
    [Abstract] [Full Text] [Related]

  • 22. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.
    Welkos S, Little S, Friedlander A, Fritz D, Fellows P.
    Microbiology (Reading); 2001 Jun 01; 147(Pt 6):1677-1685. PubMed ID: 11390699
    [Abstract] [Full Text] [Related]

  • 23. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
    Bielinska AU, Janczak KW, Landers JJ, Makidon P, Sower LE, Peterson JW, Baker JR.
    Infect Immun; 2007 Aug 01; 75(8):4020-9. PubMed ID: 17502384
    [Abstract] [Full Text] [Related]

  • 24. Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein.
    Price BM, Liner AL, Park S, Leppla SH, Mateczun A, Galloway DR.
    Infect Immun; 2001 Jul 01; 69(7):4509-15. PubMed ID: 11401993
    [Abstract] [Full Text] [Related]

  • 25. Recombinant vaccine displaying the loop-neutralizing determinant from protective antigen completely protects rabbits from experimental inhalation anthrax.
    Oscherwitz J, Yu F, Jacobs JL, Cease KB.
    Clin Vaccine Immunol; 2013 Mar 01; 20(3):341-9. PubMed ID: 23283638
    [Abstract] [Full Text] [Related]

  • 26. A plant-produced protective antigen vaccine confers protection in rabbits against a lethal aerosolized challenge with Bacillus anthracis Ames spores.
    Chichester JA, Manceva SD, Rhee A, Coffin MV, Musiychuk K, Mett V, Shamloul M, Norikane J, Streatfield SJ, Yusibov V.
    Hum Vaccin Immunother; 2013 Mar 01; 9(3):544-52. PubMed ID: 23324615
    [Abstract] [Full Text] [Related]

  • 27. A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores.
    Hermanson G, Whitlow V, Parker S, Tonsky K, Rusalov D, Ferrari M, Lalor P, Komai M, Mere R, Bell M, Brenneman K, Mateczun A, Evans T, Kaslow D, Galloway D, Hobart P.
    Proc Natl Acad Sci U S A; 2004 Sep 14; 101(37):13601-6. PubMed ID: 15342913
    [Abstract] [Full Text] [Related]

  • 28. Immunogenicity of Bacillus anthracis protective antigen domains and efficacy of elicited antibody responses depend on host genetic background.
    Abboud N, Casadevall A.
    Clin Vaccine Immunol; 2008 Jul 14; 15(7):1115-23. PubMed ID: 18480236
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Aerosolized Intratracheal Inoculation of Recombinant Protective Antigen (rPA) Vaccine Provides Protection Against Inhalational Anthrax in B10.D2-Hc0 Mice.
    Song X, Zhang W, Zhai L, Guo J, Zhao Y, Zhang L, Hu L, Xiong X, Zhou D, Lv M, Yang W.
    Front Immunol; 2022 Jul 14; 13():819089. PubMed ID: 35154137
    [Abstract] [Full Text] [Related]

  • 32. A bivalent protein r-PB, comprising PA and BclA immunodominant regions for comprehensive protection against Bacillus anthracis.
    Majumder S, Das S, Somani V, Makam SS, Joseph KJ, Bhatnagar R.
    Sci Rep; 2018 May 08; 8(1):7242. PubMed ID: 29740033
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A single-dose PLGA encapsulated protective antigen domain 4 nanoformulation protects mice against Bacillus anthracis spore challenge.
    Manish M, Rahi A, Kaur M, Bhatnagar R, Singh S.
    PLoS One; 2013 May 08; 8(4):e61885. PubMed ID: 23637922
    [Abstract] [Full Text] [Related]

  • 36. Protective effect of Bacillus anthracis surface protein EA1 against anthrax in mice.
    Uchida M, Harada T, Enkhtuya J, Kusumoto A, Kobayashi Y, Chiba S, Shyaka A, Kawamoto K.
    Biochem Biophys Res Commun; 2012 May 04; 421(2):323-8. PubMed ID: 22507985
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. A combination of the TLR4 agonist CIA05 and alum promotes the immune responses to Bacillus anthracis protective antigen in mice.
    Wui SR, Kim HK, Han JE, Kim JM, Kim YH, Chun JH, Cho YJ, Lee NG.
    Int Immunopharmacol; 2011 Sep 04; 11(9):1195-204. PubMed ID: 21492746
    [Abstract] [Full Text] [Related]

  • 40. Generation of protective immune response against anthrax by oral immunization with protective antigen plant-based vaccine.
    Gorantala J, Grover S, Rahi A, Chaudhary P, Rajwanshi R, Sarin NB, Bhatnagar R.
    J Biotechnol; 2014 Apr 20; 176():1-10. PubMed ID: 24548460
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.